| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/05/2008 | WO2008034909A3 Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| 06/05/2008 | WO2007107246A3 SUBSTITUTED 2-AMINO-4-PHENYL-DιHYDROQUINOLINES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS MEDICAMENTS, AND MEDICAMENTS CONTAINING THEM |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132573 ricinoleic acid derivatives; transient receptor potential vanilloid (cannabinoid receptor) agonist; neuroprotective effect against glutamate excitotoxicity, antiemetic; urinary incontinence, for the relief of neuropathic pain, intestinal inflammatory disorders |
| 06/05/2008 | US20080132567 Alpha-Aminoamide Derivatives Useful in the Treatment of Lower Urinary Tract Disorders |
| 06/05/2008 | US20080132538 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 06/05/2008 | US20080132494 Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 06/05/2008 | US20080132483 Administering (3R,5S)-N-propanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetamide; cerebral infarction |
| 06/05/2008 | US20080132447 kit; oligonucleotide; diagnose and treat carnitine deficiency |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease |
| 06/05/2008 | DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent |
| 06/05/2008 | CA2670976A1 Cyclic amine compound |
| 06/05/2008 | CA2668579A1 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 06/05/2008 | CA2668124A1 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide |
| 06/04/2008 | EP1927362A2 Alphavbeta3integrin as a predictor of endometriosis |
| 06/04/2008 | EP1927352A2 Therapeutic methods and compositions involving isoflavones |
| 06/04/2008 | EP1469853B1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-d-pyrimidine for treating of urinary incontinence |
| 06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
| 06/04/2008 | EP1343775B1 Piperazine derivatives |
| 06/04/2008 | EP1318821B1 Fluid for haemofiltration |
| 06/04/2008 | EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 06/04/2008 | CN101193638A Therapeutic combination in case of benign prostate hyperplasia |
| 06/04/2008 | CN101190890A 5-[(2R)-[2-[2-[2-(2,2,2-trifluoroethoxyl)phenoxyl]ethyl]amino]propyl]-2-methoxylbenzsulfamide |
| 06/04/2008 | CN101190327A í«Kanlijiaobuyeí» a kind of traditional Chinese medicinal oral liquid |
| 06/04/2008 | CN101190321A Proprietary Chinese medicine preparations for treating uric acid nephropathy and preparation method thereof |
| 06/04/2008 | CN101190308A Ginseng deer kidney-invigorating traditional Chinese medicine preparation and preparation method thereof |
| 06/04/2008 | CN101190291A í«Tianjingzhongzigaoí» (an externally-applied plaster) special for treating soreness and weakness of the loins and knees |
| 06/04/2008 | CN101190023A Health care food for strengthening kidney and blackening hair and its manufacturing method |
| 06/04/2008 | CN100391942C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing same and their use in medicaments |
| 06/04/2008 | CN100391935C Cyclopentyl derivates |
| 06/04/2008 | CN100391544C The E type DNA vaccine of Chlamydi trachomatis and its preparation methods and applications |
| 06/04/2008 | CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 06/04/2008 | CN100391534C Modulation of smooth muscle cell proliferation |
| 06/04/2008 | CN100391509C Prostate medincine wine |
| 06/04/2008 | CN100391459C Doxazosin mesilate slow releasing preparation |
| 06/04/2008 | CN100391440C Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base |
| 06/03/2008 | US7381840 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/03/2008 | US7381808 Method and nucleic acids for the differentiation of prostate tumors |
| 06/03/2008 | US7381807 Of given nucleotide sequence; encapsulated in slow release delivery vehicle; includes viral or bacterial antigen; increases cell proliferation, differentiation, cytokine and antibody production for lymphocytes |
| 06/03/2008 | US7381729 Gastrointestinal fluid solubility; adenosine-1 receptor agonist; hypertension, congestive heart failure, renal failure |
| 06/03/2008 | US7381709 Method of expressing foreign gene in kidney |
| 06/03/2008 | US7381704 Methods for use of short bioactive peptides |
| 06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
| 06/03/2008 | US7381429 Hormone replacemnent therapy; menopause, osteoporosis, cardiovascular disorders; stroke; sexual disorders |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2368186C Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 05/29/2008 | WO2008063772A2 Resolvin d series and protectin d1 mitigate acute kidney injury |
| 05/29/2008 | WO2008062861A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 05/29/2008 | WO2008062830A1 Spiroquinone compound and pharmaceutical composition |
| 05/29/2008 | WO2008062740A1 Nitrogenated fused ring compound and use thereof |
| 05/29/2008 | WO2008062437A2 Process for the preparation of sevelamer hydrochloride and formulation thereof |
| 05/29/2008 | WO2008034011A3 Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | US20080125495 Ameliorant For Renal Insufficiency |
| 05/29/2008 | US20080125484 Synthetic Lactone Formulations and Methods of Use |
| 05/29/2008 | US20080125394 Continuous slow release of a oral drug containing phosphorus binder such as polyallylamine HCL, polyallylamine carbonate, lanthanum carbonate, Al/OH/3, magnesium acetate, MgCO3, CaCO3, calcium acetate, calcium citrate, calcium alginate, styrene-divinylbenzene copolymer, chitosan for hyperphosphatemia |
| 05/29/2008 | US20080125391 administering to a mammal harboring a tumor which expresses HALRs, a Sindbis virus vector to treat the tumor, and the vector has not been modified to target a tumor-specific cellular determinant, has a preferential affinity for HALRs, a Sindbis virus E2 HALR binding domain; ganciclovir; gene therapy |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124413 Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation hypersensitivity or pain |
| 05/29/2008 | US20080124405 Composition for Prophylaxis or Treatment of Urinary System Infection and Method Thereof |
| 05/29/2008 | US20080124384 Heteroaryl Substituted Piperazinyl-Pyridine Analogues |
| 05/29/2008 | US20080124336 Molecules and Methods for Inhibiting Shedding of KIM-1 |
| 05/28/2008 | EP1925677A2 Marker genes for determining renal toxicity |
| 05/28/2008 | EP1924566A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 05/28/2008 | EP1924565A1 Diaminopyrimidines as p2x3 and p3x2/3 modulators |
| 05/28/2008 | EP1924564A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1546098B1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | CN101185759A Anti-angiogene compositions and methods of use |
| 05/28/2008 | CN101185698A Effective substance extracted from bastard speedwell for treating prostatitis and prostatic hyperplasia |
| 05/28/2008 | CN101185662A Method and use for preparing novel medicine for treating diabetes prepared from tuber fern |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100389796C Chinese medicinal preparation for treating chronic prostatitis and its manufacturing method |
| 05/28/2008 | CN100389794C Medicine for treating chronic kidney failure and its preparing process |
| 05/28/2008 | CN100389665C Method for preparing kidney-replenishing health-preserving milk tablet with micron antler powder, tortoise plastron powder, curculigo rhizome powder, walnut kernel powder, dried solomonseal powder |
| 05/28/2008 | CN100389664C Method for preparing kidney-replenishing health-preserving soybean milk tablet with micron antler powder, tortoise plastron powder, curculigo rhizome powder, walnut kernel powder, dried solomonseal po |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378444 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 05/27/2008 | US7378436 Substituted N-[pyrrolidin-3-yl] benzamides or naphthamides; serotonin and noradrenaline receptor antagonists; urinary incontinence; arylation of the amino pyrrolidine with a carboxylic acid or acyl halide and then deprotecting |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378428 phosphodiesterase inhibitors; (Z)-2-(7-bromomethyl-3,3-dimethyl-3,4-dihydro-(2H)-isoquinolin-1-ylidene)-1-(adamantan-1-yl)ethan-1-one; graft versus host disease, osteoporosis, bone fracture, restenosis, arteriosclerosis, obesity, ischemic reperfusion injury, depression, allergies, transplant rejection |
| 05/27/2008 | US7378408 Methods of treatment and formulations of cephalosporin |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/22/2008 | WO2008061247A2 Benzenesulfonanilide compound inhibitors of urea transporters |
| 05/22/2008 | WO2008059854A1 Piperidine derivatives or salts thereof |
| 05/22/2008 | WO2008030638A3 Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders |
| 05/22/2008 | WO2008021550A3 Thiol-based agents for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 05/22/2008 | US20080119534 Benzimidazole Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119525 Pyridoxamine for the Treatment of Diabetic Intermediaries and Post-Amadori Inhibition |